New Landmark Study Indicates UltraSight Enables Novice Ultrasound Users to Capture High Quality Cardiac Images
Summary
November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, today announced new findings from a landmark pivotal study. It evaluated 2D transthoracic echocardiography images acquired by nine residents and registered nurses, none of whom had prior cardiac ultrasound experience, using UltraSight’s AI real-time guidance software. After undergoing a one-day training course, the novice ultrasound users scanned 240 cardiac patients and acquired 10 standard echocardiography views. The UltraSight AI guidance system aims to help bring the benefits of cardiac imaging to more healthcare professionals in new care settings and allow patients access to ultrasound anywhere. Recently, UltraSight obtained a CE Mark for its AI guidance software for cardiac ultrasound, and it is now available in the European Union to institutions interested in using it for clinical trials.
Classifications
AskAI Classifications
LabelsLinked Companies
